Johnson & Johnson Collaborates with the Government of Canada to Supply its Ad26.COV2.S for COVID-19

 Johnson & Johnson Collaborates with the Government of Canada to Supply its Ad26.COV2.S for COVID-19

Johnson & Johnson Collaborates with Government of Canada to Supply its Ad26.COV2.S for COVID-19

Shots:

  • Janssen signs an agreement in principle with the Government of Canada to supply its COVID-19 vaccine, ensuring broad Canadian access to Ad26.COV2.S, following Health Canada’s approval
  • In addition, a final agreement will be determined in due course under which the Government of Canada would purchase ~38M doses of Janssen’s vaccine candidate on a not-for-profit basis for emergency pandemic use
  • The vaccine is currently being evaluated in P-I/IIa study in the US and Belgium while the company is planning for conducting P-III study following interim data of the P-I/IIa studies and approval of regulators

Click here ­to­ read full press release/ article | Ref: J&J  | Image: TrialSite News

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post